Nath Bio-GenesQ1 FY26
Nath Bio-Genes Q1 FY26 Earnings Call Analysis
Revenue, margin, capex, fundraise and order book outlook from management commentary.
Price: ₹161P/E: 9.2Market Cap: ₹313 CrSector: Agricultural Food & other Products
Management growth scorecard
Revenue
N/A
Margin
N/A
Fundraise
N/A
Order
N/A
Capex
N/A
0 of 0 growth signals are positive — mixed outlook.
Full analysisRevenue guidance
No information is provided regarding the same in the latest conference call.
Margin guidance
No information is provided regarding the same in the latest conference call.
3 more insights locked — sign up free to unlock
Fundraise plans
No information is provided regarding the same in the latest conference call.
Order book
No information is provided regarding the same in the latest conference call.
Capex plans
No information is provided regarding the same in the latest conference call.
How does Nath Bio-Genes rank vs peers in Agricultural Food & other Products?
Pro feature1Nath Bio-Genes
See full Agricultural Food & other Products sector rankings
Want more stocks like Nath Bio-Genes?
Build an AI portfolio filtered by sector, market cap, and growth rank. Takes 2 minutes.
Build my portfolio